UBQLN4 regulates cisplatin-resistance in Triple-Negative Breast Cancer by targeting BAT3 for proteasomal degradation. AACR Breast Cancer San Antonio Symp, Abrs Nr P4-01-1,  2021.

Y Shoji; Dave S.B. Hoon; Matias Bustos; See all authors in notes

UBQLN4 regulates cisplatin-resistance in Triple-Negative Breast Cancer by targeting BAT3 for proteasomal degradation. AACR Breast Cancer San Antonio Symp, Abrs Nr P4-01-1, 2021.

Y Shoji
, Dave S.B. Hoon
, Matias Bustos
, See all authors in notes

Research output: Contribution to conference › Abstract

Original language	American English
State	Published - 2021

Cite this

@conference{53c7d63229ee465d9ac5d29313445676,

title = "UBQLN4 regulates cisplatin-resistance in Triple-Negative Breast Cancer by targeting BAT3 for proteasomal degradation. AACR Breast Cancer San Antonio Symp, Abrs Nr P4-01-1, 2021.",

author = "Y Shoji and Hoon, \{Dave S.B.\} and Matias Bustos and \{See all authors in notes\}",

note = "282. Shoji Y, Takamichi Y, Bostick P, Shiloh Y, Hoon DSB, Bustos MA",

year = "2021",

language = "American English",

}

TY - CONF

T1 - UBQLN4 regulates cisplatin-resistance in Triple-Negative Breast Cancer by targeting BAT3 for proteasomal degradation. AACR Breast Cancer San Antonio Symp, Abrs Nr P4-01-1, 2021.

AU - Shoji, Y

AU - Hoon, Dave S.B.

AU - Bustos, Matias

AU - See all authors in notes,

N1 - 282. Shoji Y, Takamichi Y, Bostick P, Shiloh Y, Hoon DSB, Bustos MA

PY - 2021

Y1 - 2021

M3 - Abstract

ER -